Package 63323-102-94

Brand: gemcitabine

Generic: gemcitabine
NDC Package

Package Facts

Identity

Package NDC 63323-102-94
Digits Only 6332310294
Product NDC 63323-102
Product ID 63323-102_4c447f74-d06c-459b-ba63-6b72aaf4fd2e
Description

1 VIAL, SINGLE-DOSE in 1 BOX (63323-102-94) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2011-07-26
Brand gemcitabine
Generic gemcitabine
Sample Package No

Linked Drug Pages (1)

GEMCITABINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4c447f74-d06c-459b-ba63-6b72aaf4fd2e", "openfda": {"upc": ["0363323125943", "0363323102944"], "unii": ["U347PV74IL"], "rxcui": ["1719000", "1719003"], "spl_set_id": ["d1f3951c-d13f-4662-ad4b-ecfc07f59104"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 BOX (63323-102-94)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-102-94", "marketing_start_date": "20110726"}], "brand_name": "GEMCITABINE", "product_id": "63323-102_4c447f74-d06c-459b-ba63-6b72aaf4fd2e", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "63323-102", "generic_name": "GEMCITABINE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GEMCITABINE", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "200 mg/5mL"}], "application_number": "ANDA090799", "marketing_category": "ANDA", "marketing_start_date": "20110726", "listing_expiration_date": "20261231"}